BPMC - Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q4 2020 Results - Earnings Call Transcript

Blueprint Medicines Corporation (BPMC) Q4 2020 Results Conference Call February 17, 2021 08:30 AM ET Company Participants Kristin Hodous - Senior Manager, IR Jeff Albers - CEO Christy Rossi - Chief Commercial Officer Fouad Namouni - President, Research and Development Mike Landsittel - CFO Conference Call Participants Marc Frahm - Cowen and Company Dane Leone - Raymond James Charles Zhu - Guggenheim David Lebowitz - Morgan Stanley Peter Lawson - Barclays Arlinda Lee - Canaccord Eun Yang - Jefferies Michael Ulz - Robert W. Baird Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to the Blueprint Medicines Fourth Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I’d now like to hand the conference over to your speaker

For further details see:

Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q4 2020 Results - Earnings Call Transcript